BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 4956684)

  • 1. [Effect of bone marrow homotransplantation on the toxicity and antineoplastic property of some alkylating agents].
    Veksler IG; Shevchenko VN
    Vopr Onkol; 1965; 11(7):71-6. PubMed ID: 4956684
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of thiotepa in allogeneic bone marrow transplantation for genetic diseases.
    Rosales F; Peylan-Ramu N; Cividalli G; Varadi G; Or R; Naparstek E; Slavin S; Nagler A
    Bone Marrow Transplant; 1999 May; 23(9):861-5. PubMed ID: 10338039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thiotepa improves allogeneic bone marrow engraftment without enhancing stem cell depletion in irradiated mice.
    Down JD; Westerhof GR; Boudewijn A; Setroikromo R; Ploemacher RE
    Bone Marrow Transplant; 1998 Feb; 21(4):327-30. PubMed ID: 9509964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of alkylating agents by lonidamine in vivo.
    Teicher BA; Holden SA; Herman TS; Frei E
    Semin Oncol; 1991 Apr; 18(2 Suppl 4):7-10. PubMed ID: 1903216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Study of new immunodepressants among antineoplastic agents].
    Drake RB; Grigalinovich GA; Kalnberz VK; Lidak MIu
    Vestn Akad Med Nauk SSSR; 1971; 26(1):31-3. PubMed ID: 4928209
    [No Abstract]   [Full Text] [Related]  

  • 6. The mechanisms of action of antitumor compounds.
    Belousova AK
    Natl Cancer Inst Monogr; 1977 Mar; (45):183-93. PubMed ID: 73135
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacological studies of the mechanism of tumor-induced bone marrow cytolysis.
    DiStefano JF; Lysik R; Zucker S
    Cancer Res; 1979 Apr; 39(4):1193-8. PubMed ID: 421203
    [No Abstract]   [Full Text] [Related]  

  • 8. Antitumour alkylating agents: cytotoxic action and organ toxicity.
    Connors TA
    IARC Sci Publ; 1986; (78):143-5. PubMed ID: 3583387
    [No Abstract]   [Full Text] [Related]  

  • 9. The biology of alkylating-agent cellular injury.
    Shulman LN
    Hematol Oncol Clin North Am; 1993 Apr; 7(2):325-35. PubMed ID: 8468267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implications of a proliferative limitation on hematopoietic stem cells.
    Hellman S; Mauch P
    Prog Clin Biol Res; 1984; 148():51-8. PubMed ID: 6379673
    [No Abstract]   [Full Text] [Related]  

  • 11. Homologous marrow transplantation in rabbits after triethylenethiophosphoramide.
    PORTER KA; MURRAY JE
    AMA Arch Surg; 1958 Jun; 76(6):908-11. PubMed ID: 13532133
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of some antiblastic drugs on HeLa cells.
    D'Ancona S; Adami P; Pederzoli G
    Boll Ist Sieroter Milan; 1976; 55(2):174-84. PubMed ID: 1023885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison of some biochemical and hematologic characteristics in radiation sickness and under the effects of alkylating agents for instance thioTEPA].
    Alesenko AV; Burlakova EB; Dziuba NM; Slepukhina LV; Emanuél' NM
    Radiobiologiia; 1966; 6(5):718-23. PubMed ID: 4964759
    [No Abstract]   [Full Text] [Related]  

  • 14. [The influence of some alkylating antiblastic drugs and antimetabolites on the healing process of fracture foci. (Experimental research)].
    Mangione F; Taverna L
    Boll Soc Ital Biol Sper; 1964 Dec; 40(24):1711-2. PubMed ID: 5877911
    [No Abstract]   [Full Text] [Related]  

  • 15. [Formation of precipitation areas in immunization with the alkylating compounds Lonin-3 and K-4].
    Montsevichiute-Eringene
    Biull Eksp Biol Med; 1968 Mar; 65(3):91-4. PubMed ID: 4967813
    [No Abstract]   [Full Text] [Related]  

  • 16. Mode of action of anticancer agents on iron metabolism in tumor-bearing mice. I. Combination therapy with anticancer agents and iron compounds.
    Hano K; Akashi A
    Gan; 1965 Aug; 56(4):377-84. PubMed ID: 4954024
    [No Abstract]   [Full Text] [Related]  

  • 17. Alkylating agents.
    Connors TA
    Cancer Chemother Biol Response Modif; 1990; 11():29-44. PubMed ID: 2223396
    [No Abstract]   [Full Text] [Related]  

  • 18. Transforming growth factor-beta 1 overexpression produces drug resistance in vivo: reversal by decorin.
    Teicher BA; Ikebe M; Ara G; Keyes SR; Herbst RS
    In Vivo; 1997; 11(6):463-72. PubMed ID: 9509296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alkylating agents.
    Connors TA
    Cancer Chemother Biol Response Modif; 1992; 13():31-44. PubMed ID: 1389913
    [No Abstract]   [Full Text] [Related]  

  • 20. [Membrane mechanisms of the effect of alkylating cytostatic agents].
    Mukhin VV; Poda GI; Luĭk AI; Baldenkov GN
    Biull Eksp Biol Med; 1990 Apr; 109(4):351-3. PubMed ID: 2386826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.